The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, November 15, 2023
Absci Corporation and Almirall S.A. announced a drug discovery partnership aimed to develop and commercializing AI-designed therapeutics to fight ...
read more
Tuesday, November 14, 2023
The PACIFIC-2 Phase III trial for Imfinzi (durvalumab) concurrently administered with chemoradiotherapy (CRT) did not achieve statistical significance...
read more
Thursday, November 09, 2023
AstraZeneca and Eccogene entered an exclusive license agreement for ECC5004, an investigational oral once-daily glucagon-like peptide 1 receptor ...
read more
Monday, November 06, 2023
Upsher-Smith Labs announced the launch of Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg strengths.
read more
Tuesday, October 24, 2023
AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has accepted its application for the self-administration of the FluMist ...
read more
Hyloris Pharmaceuticals SA announced that Maxigesic® IV has been approved for the relief of mild to moderate pain and for the management of moderate ...
read more
Enable Injections announced that the FDA approved the EMPAVELI Injector (enFuse®) for the subcutaneous delivery of EMPAVELI® (pegcetacoplan), which is...
read more
Thursday, September 28, 2023
HitGen announced a partnership with The Structural Genomics Consortium ("SGC"), a public-private partnership that supports the discovery of new ...
read more
Wednesday, September 06, 2023
XtalPi, a provider of AI-powered drug discovery solutions, and Parthenon Therapeutics, a clinical-stage biotechnology company dedicated to ...
read more
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA (long-acting) capsules,60 ...
read more
UPMC announced a collaboration with PharmaLogic Holdings Corp. to facilitate the development of novel radiopharmaceuticals for the diagnosis and ...
read more
ANNEXA-I, a post-marketing Phase IV trial to assess the efficacy and safety of Andexxa (andexanet alfa) in patients on oral FXa-inhibitor treatment ...
read more
The FDA has approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-...
read more
Biomea Fusion, Inc announced that the FDA cleared the Investigational New Drug (IND) application to begin a Phase I trial (COVALENT-103) of BMF-500, ...
read more
Premier Research announced the addition of Kenneth Ndugga-Kabuye, M.D., FACMG, as VP, Cell & Gene Therapy to the strategic Cell & Gene Therapy (CGT) ...
read more